BioRestorative Therapies Inc (BRTX) financials · rev $359.7K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
BioRestorative Therapies Inc (BRTX) rev $359.7K.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $359.7K | $401.0K |
| Cost of Revenue | $23.8K | $28.1K |
| Gross Profit | $335.9K | $372.9K |
| Operating Income | -$15.6M | -$11.6M |
| Net Income | -$14.2M | -$8.98M |
| EPS (Diluted) | -$1.58 | -$1.16 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4.08M | $12.3M |
| Current Assets | $3.14M | $11.1M |
| Cash & Equivalents | $1.51M | $547.9K |
| PP&E | $358.8K | $362.9K |
| Total Liabilities | $3.72M† | $3.75M |
| Current Liabilities | $3.72M | $3.75M |
| Shareholders' Equity | $356.7K | $8.53M |
| Retained Earnings | -$169.9M | -$155.7M |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$10.8M | -$8.23M |
| CapEx | $116.1K | $106.2K |
| Investing Cash Flow | $8.90M | $514.5K |
| Financing Cash Flow | $2.85M | $7.38M |
| Net Change in Cash | $963.3K | -$336.5K |
| Free Cash Flow | -$10.9M | -$8.34M |
FAQ
What is BRTX P/E and revenue?
BioRestorative Therapies Inc (BRTX) rev $359.7K.
What is BRTX revenue?
BioRestorative Therapies Inc last cached revenue is $359.7K (FY2025).
Is BRTX profitable?
BioRestorative Therapies Inc last cached net income is -$14.2M (FY2025).
What are BRTX total assets?
BioRestorative Therapies Inc last cached total assets are $4.08M (FY2025).
What is BRTX free cash flow?
BioRestorative Therapies Inc last cached free cash flow is -$10.9M (FY2025).
Not investment advice. Cached statements, not a live tape.